FB2026_03 , released September 17, 2026
Human Disease Model Report: cardiomyopathy, familial hypertrophic 10
Open Close
General Information
Name
cardiomyopathy, familial hypertrophic 10
FlyBase ID
FBhh0001223
Overview

This report describes cardiomyopathy, familial hypertrophic 10 (CMH10), a subtype of familial hypertrophic cardiomyopathy. CMH10 typically exhibits autosomal dominant inheritance, but a severe recessive form has recently been characterized. The gene implicated in this disease is MYL2, which encodes a myosin regulatory light chain. There are multiple myosin light chain genes in both human and flies. In Drosophila, the gene most closely related to human MYL2 is Mlc2, for which a classic loss-of-function allele, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated.

Multiple UAS constructs of human Hsap\MYL2 have been introduced into flies, including wild-type and variants implicated in disease. Partial heterologous rescue (functional complementation) of Dmel\Mlc2 heart-specific phenotypes is observed using the wild-type human gene, but not for the variants characterized. Variant(s) implicated in human disease tested (as transgenic human gene, MYL2): the G162R and P144,fs variant forms of the human gene have been introduced into flies. This frameshift variant is associated with the severe recessive form of CMH10.

Animals homozygous for a loss-of-function allele of Dmel\Mlc2 typically die during the embryonic stage; heterozygotes exhibit a flightless phenotype due to sarcomeric structural abnormalities affecting the indirect flight muscles. Knockdown of Mlc2 specifically in the heart, effected by RNAi, results in abnormalities in larval heart contraction rhythm and reduced viability to adulthood. Genetic and physical interactions have been described for Dmel\Mlc2; see below and in the Mlc2 gene report.

[updated Jul. 2020 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: cardiomyopathy, familial hypertrophic
Symptoms and phenotype

Familial hypertrophic cardiomyopathy is a heart condition characterized by thickening (hypertrophy) of cardiac muscle. Thickening usually occurs in the interventricular septum, the muscular wall that separates the left ventricle from the right ventricle. Cardiac hypertrophy often begins in adolescence or young adulthood, although it can develop at any time throughout life. The symptoms are variable, even within the same family. While most people this condition are symptom-free or have only mild symptoms, hypertrophic cardiomyopathy can cause abnormal heart rhythms (arrhythmias) that may be life threatening. People with familial hypertrophic cardiomyopathy have an increased risk of sudden death, even if they have no other symptoms of the condition. A small number of affected individuals develop potentially fatal heart failure, which may require heart transplantation. [from Genetics Home Reference, familial hypertrophic cardiomyopathy; 2016.10.13]

Hypertrophic cardiomyopathy in early stages produces a presystolic gallop due to an atrial heart sound, and EKG changes of ventricular hypertrophy. Progressive ventricular outflow obstruction may cause palpitation associated with arrhythmia, congestive heart failure, and sudden death. Hypertrophic cardiomyopathy accounts for a significant number (exceeding 25% in one study) of sudden deaths of young athletes. [from MIM:192600; 2016.10.28]

Specific Disease Summary: cardiomyopathy, familial hypertrophic 10
OMIM report

[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10](https://omim.org/entry/608758)

Human gene(s) implicated

[MYOSIN, LIGHT CHAIN 2, REGULATORY, CARDIAC, SLOW; MYL2](https://omim.org/entry/160781)

Symptoms and phenotype
Genetics

CMH10 typically exhibits autosomal dominant inheritance (MIM:608758), but a severe recessive form has recently been characterized (FBrf0245856).

Familial hypertrophic cardiomyopathy-10 (CMH10) is caused by mutation in the MYL2 gene. [from MIM:608758; 2020.07.19]

Cellular phenotype and pathology
Molecular information

Myosins are a large family of motor proteins that share the common features of ATP hydrolysis, actin binding and potential for kinetic energy transduction. MYL2 encodes the regulatory light chain associated with cardiac myosin beta heavy chain. Ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction. [Gene Cards, MYL2; 2020.07.19]

Myosin light chain-2 (MYL2) is an important protein in the regulation of myosin ATPase activity in smooth muscle. [from MIM:160781; 2020.07.19]

External links
Disease synonyms
cardiomyopathy, hypertrophic, mid-left ventricular chamber type 2
CMH10
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to many: multiple related genes in both species. Most closely related to Drosophila Mlc2.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Snapshot
    Myosin light chain 2 (Mlc2) encodes a subunit of the myosin complex involved in myofibril assembly. It contributes to different flight-related processes including wing beat frequency, and indirect flight muscle contraction. [Date last reviewed: 2019-07-11]
    Cellular component (GO)
    Gene Groups / Pathways
    Comments on ortholog(s)

    Multiple related genes in both species; most closely related to human MYL2.

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (47 groups)
      protein-protein
      Interacting group
      Assay
      References
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      Alleles Reported to Model Human Disease (Disease Ontology) (4 alleles)
      Models Based on Experimental Evidence ( 2 )
      Modifiers Based on Experimental Evidence ( 1 )
      Allele
      Disease
      Interaction
      References
      Models Based on Experimental Evidence ( 1 )
      Allele
      Disease
      Evidence
      References
      Modifiers Based on Experimental Evidence ( 1 )
      Allele
      Disease
      Interaction
      References
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      amorphic allele - genetic evidence
      ethyl methanesulfonate
      References (6)